Does stopping a GLP-1 really doom you to regain all the weight?
Recent studies examine the long-term impact of discontinuing GLP-1 weight-loss medications like Ozempic and Wegovy.
4 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 1 news category, from Jul 2, 2026 through Jul 17, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
Recent studies examine the long-term impact of discontinuing GLP-1 weight-loss medications like Ozempic and Wegovy.
Emerging research links late-night eating patterns in 'night owls' to elevated risks of metabolic disease and poor heart health.
New clinical guidelines and reports are highlighting cardiovascular-kidney-metabolic syndrome as a significant health trend affecting 90 percent of U.S. adults.
New research suggests statins and blood pressure medications are narrowing the heart risk gap between adults with obesity and those of a healthy weight.